Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study

A Dose Finding Study of a Wild-Type Influenza A/H3N2 virus in a Healthy Volunteer Human Challenge Model

(2019) Alison Han et al.   CLINICAL INFECTIOUS DISEASES

Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness

(2018) Melissa A. Rolfes et al.   Influenza and Other Respiratory Viruses

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

(2018) A Danielle Iuliano et al.   LANCET

Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI)

(2018) John H. Powers et al.   PLoS One

Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

(2018) John H. Powers et al.   VALUE IN HEALTH

Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus

(2018) Jae-Keun Park et al.   mBio

Using the Influenza Patient-reported Outcome (FLU-PRO) diary to evaluate symptoms of influenza viral infection in a healthy human challenge model

(2018) Alison Han et al.   BMC INFECTIOUS DISEASES

Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine

(2017) Eva van Doorn et al.   MEDICINE

Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017

(2017) Brendan Flannery et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model

(2016) Matthew J. Memoli et al.   mBio

A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans

(2015) Olga Pleguezuelos et al.   Clinical and Vaccine Immunology

Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review

(2015) Eva van Doorn et al.   Human Vaccines & Immunotherapeutics

Combining one-sample confidence procedures for inference in the two-sample case

(2014) Michael P. Fay et al.   BIOMETRICS

Validation of the Wild-type Influenza A Human Challenge Model H1N1pdMIST: An A(H1N1)pdm09 Dose-Finding Investigational New Drug Study

(2014) Matthew J. Memoli et al.   CLINICAL INFECTIOUS DISEASES

Correlates of protection to influenza virus, where do we go from here?

(2013) Rebecca Cox   Human Vaccines & Immunotherapeutics

Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine

(2012) Jacob Atsmon et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial

(2012) Olga Pleguezuelos et al.   VACCINE

Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine

(2011) Wilbur H. Chen et al.   VACCINE

Antibody response to the influenza vaccine in healthcare workers

(2011) Ema Sacadura-Leite et al.   VACCINE

T-cell exhaustion: characteristics, causes and conversion

(2010) John S. Yi et al.   IMMUNOLOGY

Partial CD4 Depletion Reduces Regulatory T Cells Induced by Multiple Vaccinations and Restores Therapeutic Efficacy

(2009) M. G. LaCelle et al.   CLINICAL CANCER RESEARCH